Application 761457

Type
BLA
Sponsor
AMNEAL PHARMS LLC

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761457Oziltusdenosumab-mobz351(k) InterchangeableRx2026-06-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OZILTUSDENOSUMAB-MOBZINJECTABLE;SUBCUTANEOUS120MG/1.7ML (70MG/ML)NoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OziltusDENOSUMAB-MOBZAmneal Pharmaceuticals LLCf040a245-1be4-4962-a8b7-a13ee7fac7072025-12-22Warnings, Adverse reactionsExact identifier
application number: BLA761457

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84691ORIG 2026-01-06
84519ORIG 2025-12-23